ABIOMED INC Quarterly Costs and Expenses in USD from Q2 2010 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Abiomed Inc quarterly/annual Costs and Expenses history and growth rate from Q2 2010 to Q3 2022.
  • Abiomed Inc Costs and Expenses for the quarter ending September 30, 2022 was $208M, a 10.8% increase year-over-year.
  • Abiomed Inc Costs and Expenses for the twelve months ending September 30, 2022 was $820M, a 0.95% decline year-over-year.
  • Abiomed Inc annual Costs and Expenses for 2021 was $891M, a 44.2% increase from 2020.
  • Abiomed Inc annual Costs and Expenses for 2020 was $618M, a 4.45% increase from 2019.
  • Abiomed Inc annual Costs and Expenses for 2019 was $592M, a 8.64% increase from 2018.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $820M $208M +$20.2M +10.8% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $800M $211M -$90.8M -30.1% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $891M $205M +$26.4M +14.8% Jan 1, 2022 Mar 31, 2022 10-K 2022-05-20
Q4 2021 $865M $197M +$36.3M +22.6% Oct 1, 2021 Dec 31, 2021 10-Q 2022-02-03
Q3 2021 $828M $188M +$39.3M +26.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $789M $302M +$171M +131% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $618M $178M +$29.8M +20.1% Jan 1, 2021 Mar 31, 2021 10-K 2022-05-20
Q4 2020 $588M $160M +$8.99M +5.94% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-03
Q3 2020 $579M $148M +$3.64M +2.51% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 $576M $131M -$16.2M -11% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $592M $149M +$6.91M +4.88% Jan 1, 2020 Mar 31, 2020 10-K 2022-05-20
Q4 2019 $585M $151M +$13.1M +9.49% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 $572M $145M +$13.3M +10.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $558M $147M +$13.7M +10.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $545M $142M +$14.8M +11.7% Jan 1, 2019 Mar 31, 2019 10-K 2021-05-21
Q4 2018 $530M $138M +$29M +26.5% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-06
Q3 2018 $501M $131M +$30.4M +30% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $470M $133M +$33.9M +34.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $437M $127M +$31.2M +32.6% Jan 1, 2018 Mar 31, 2018 10-K 2020-05-21
Q4 2017 $405M $109M +$20M +22.4% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-05
Q3 2017 $385M $101M +$12.7M +14.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $373M $99.4M +$17.6M +21.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $355M $95.7M +$21.5M +29.1% Jan 1, 2017 Mar 31, 2017 10-K 2019-05-23
Q4 2016 $334M $89.3M +$20.9M +30.6% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-06
Q3 2016 $313M $88.4M +$24.9M +39.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $288M $81.8M +$23.4M +40% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 $264M $74.1M +$19M +34.3% Jan 1, 2016 Mar 31, 2016 10-K 2018-05-24
Q4 2015 $245M $68.4M +$20M +41.4% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-03
Q3 2015 $225M $63.5M +$15.8M +33% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $210M $58.4M +$8.05M +16% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 $202M $55.2M +$8.44M +18% Jan 1, 2015 Mar 31, 2015 10-K 2017-05-25
Q4 2014 $193M $48.3M +$6.74M +16.2% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-05
Q3 2014 $186M $47.8M +$4.81M +11.2% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $182M $50.3M +$6.37M +14.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $175M $46.8M +$7.21M +18.2% Jan 1, 2014 Mar 31, 2014 10-K 2016-05-26
Q4 2013 $168M $41.6M +$6.27M +17.7% Oct 1, 2013 Dec 31, 2013 10-Q 2015-01-30
Q3 2013 $162M $42.9M +$11.5M +36.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $150M $44M +$8.76M +24.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 $142M $39.5M +$5.14M +14.9% Jan 1, 2013 Mar 31, 2013 10-K 2015-05-28
Q4 2012 $136M $35.3M +$5.37M +17.9% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-06
Q3 2012 $131M $31.5M +$2.77M +9.66% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $128M $35.2M +$3.45M +10.8% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 $125M $34.4M +$4.46M +14.9% Jan 1, 2012 Mar 31, 2012 10-K 2014-05-28
Q4 2011 $120M $30M +$2.05M +7.34% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-06
Q3 2011 $118M $28.7M +$2.29M +8.66% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-05
Q2 2011 $116M $31.8M +$3.72M +13.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-06
Q1 2011 $112M $29.9M Jan 1, 2011 Mar 31, 2011 10-K 2013-05-28
Q4 2010 $27.9M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-08
Q3 2010 $26.4M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 $28.1M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.